2024
Red blood cell alloimmunization in patients on extracorporeal membrane oxygenation
Javanbakht A, Schneider T, Hendrickson J. Red blood cell alloimmunization in patients on extracorporeal membrane oxygenation. Transfusion 2024, 64: 761-762. PMID: 38593282, DOI: 10.1111/trf.17761.Peer-Reviewed Original ResearchAnemia, Hemolytic, AutoimmuneErythrocytesExtracorporeal Membrane OxygenationHumansPatientsRetrospective Studies
2022
FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization
Qiu A, Miller A, Dei Zotti F, Santhanakrishnan M, Hendrickson JE, Tredicine M, Stowell SR, Luckey CJ, Zimring JC, Hudson KE. FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization. Frontiers In Immunology 2022, 13: 972723. PMID: 36189253, PMCID: PMC9519184, DOI: 10.3389/fimmu.2022.972723.Peer-Reviewed Original ResearchMeSH KeywordsAnemia, Hemolytic, AutoimmuneAnimalsAntibodies, BlockingAntigen-Antibody ComplexImmunoglobulin GIsoantibodiesMiceMice, KnockoutConceptsAlloantibody productionRBC alloimmunizationPassive immunizationRBC clearanceSplenic dendritic cell subsetsRed blood cell transfusionSplenic conventional DCsBlood cell transfusionDendritic cell subsetsConventional DCsFc gamma receptorsHumoral alloimmunizationAlloantibody responsesCell transfusionMaternal alloimmunizationCell subsetsFcγR expressionIgG antibodiesHemolytic diseaseBlocking antibodiesAlloimmunizationImmune complexesMouse modelKnockout miceAntibodies
2021
RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary?
Lee ES, Hendrickson JE, Tormey CA. RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary? Transfusion 2021, 61: 3283-3285. PMID: 34767268, DOI: 10.1111/trf.16736.Peer-Reviewed Original ResearchConceptsRBC alloimmunization
2010
Use of mouse models to study the mechanisms and consequences of RBC clearance
Hod E, Arinsburg S, Francis R, Hendrickson J, Zimring J, Spitalnik S. Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sanguinis 2010, 99: 99-111. PMID: 20345515, PMCID: PMC3580149, DOI: 10.1111/j.1423-0410.2010.01327.x.Peer-Reviewed Original ResearchMeSH KeywordsAnemia, Hemolytic, AutoimmuneAnimalsDisease Models, AnimalErythrocyte TransfusionErythrocytesHumansMiceConceptsMouse modelRBC clearanceImmune globulin therapyAutoimmune haemolytic anaemiaHaemolytic transfusion reactionsGlobulin therapyRBC transfusionTransfusion reactionsHaemolytic anaemiaAnimal modelsTractable animal modelTransfusion medicineCell clearanceClearancePathophysiologyHuman disordersUnanswered questionsTransfusionComplicationsAnemiaImmunomodulationTherapyMiceAntibodies